Products for Research Use Only

Praluzatamab

CAT: 0804-HY-P99788-01Size: 1 mgDry Ice: YesHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-P99788-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Praluzatamab is a monoclonal antibody targeting the activated leukocyte cell adhesion molecule (ALCAM/CD116) . Praluzatamab can be used to synthesize Praluzatamab ravtansine (antibody-drug conjugates) . Praluzatamab can be used for research of cancers[1][2].
CAS Number
2145109-70-0
UNSPSC
12352203
Target
ADC Antibody; ALCAM/CD166
Type
Inhibitory Antibodies
Related Pathways
Antibody-drug Conjugate/ADC Related; Immunology/Inflammation
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/praluzatamab.html
Purity
99.98
Solubility
10 mM in DMSO
Smiles
[Praluzatamab]
Molecular Weight
(146.9 kDa)
References & Citations
[1]Martín-Sabroso C, et al. Antibody-Antineoplastic Conjugates in Gynecological Malignancies: Current Status and Future Perspectives. Pharmaceutics. 2021 Oct 15;13 (10) :1705. |[2]Martín-Sabroso C, et al. Antibody-Antineoplastic Conjugates in Gynecological Malignancies: Current Status and Future Perspectives. Pharmaceutics. 2021 Oct 15;13 (10) :1705. |[3]Chomet M, et al. The tumor targeting performance of anti-CD166 Probody drug conjugate CX-2009 and its parental derivatives as monitored by 89Zr-immuno-PET in xenograft bearing mice. Theranostics. 2020 Apr 27;10 (13) :5815-5828.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported